Cutaneous Leishmaniasis
51
4
4
34
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.8%
6 terminated out of 51 trials
85.0%
-1.5% vs benchmark
25%
13 trials in Phase 3/4
29%
10 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (51)
Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease
Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia
Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
Miltefosine to Treat Mucocutaneous Leishmaniasis
Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
Surveillance for Leishmaniasis Skin Lesions in Mali
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco